Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation.

Izzo, J G; Wu, X; Wu, T-T; Huang, P; Lee, J-S; Liao, Z; Lee, J H; Bhutani, M S; Hofstetter, W; Maru, D; Hung, M-C; Ajani, J A

Izzo, J G; Wu, X; Wu, T-T; Huang, P; Lee, J-S; Liao, Z; Lee, J H; Bhutani, M S; Hofstetter, W; Maru, D; Hung, M-C; Ajani, J A.

Affiliation

Izzo JG; Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.

Dis Esophagus ; 22(2): 127-32, 2009.

Article in En | MEDLINE | ID: mdl-19021681

Subject(s)

Adenocarcinoma/metabolism; Esophageal Neoplasms/metabolism; NF-kappa B/metabolism; Adenocarcinoma/mortality; Adenocarcinoma/surgery; Adenocarcinoma/therapy; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms/mortality; Esophageal Neoplasms/surgery; Esophageal Neoplasms/therapy; Esophagectomy; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Prognosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Adenocarcinoma / NF-kappa B Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Dis Esophagus Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google